HK1105451A1 - Methods for antibody library screening - Google Patents

Methods for antibody library screening

Info

Publication number
HK1105451A1
HK1105451A1 HK07113709.8A HK07113709A HK1105451A1 HK 1105451 A1 HK1105451 A1 HK 1105451A1 HK 07113709 A HK07113709 A HK 07113709A HK 1105451 A1 HK1105451 A1 HK 1105451A1
Authority
HK
Hong Kong
Prior art keywords
methods
antibody library
library screening
screening
antibody
Prior art date
Application number
HK07113709.8A
Other languages
English (en)
Inventor
Marike Josee Janneke Gertrud Stassar
Herald Reiersen
Original Assignee
Affitech Res As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB0422431.7A external-priority patent/GB0422431D0/en
Priority claimed from GB0422433A external-priority patent/GB0422433D0/en
Application filed by Affitech Res As filed Critical Affitech Res As
Publication of HK1105451A1 publication Critical patent/HK1105451A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Neurology (AREA)
  • Communicable Diseases (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK07113709.8A 2004-10-08 2007-12-17 Methods for antibody library screening HK1105451A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0422431.7A GB0422431D0 (en) 2004-10-08 2004-10-08 Method
GB0422433A GB0422433D0 (en) 2004-10-08 2004-10-08 Method
PCT/GB2005/003865 WO2006038021A1 (en) 2004-10-08 2005-10-07 Methods for antibody library screening

Publications (1)

Publication Number Publication Date
HK1105451A1 true HK1105451A1 (en) 2008-02-15

Family

ID=35426982

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07113709.8A HK1105451A1 (en) 2004-10-08 2007-12-17 Methods for antibody library screening

Country Status (9)

Country Link
US (1) US20080300140A1 (xx)
EP (1) EP1802980B1 (xx)
JP (1) JP4729043B2 (xx)
AU (1) AU2005291011B2 (xx)
CA (1) CA2579937C (xx)
DK (1) DK1802980T3 (xx)
HK (1) HK1105451A1 (xx)
IL (1) IL181928A (xx)
WO (1) WO2006038021A1 (xx)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011055038A1 (fr) * 2009-11-05 2011-05-12 IFP Energies Nouvelles Fluide d'injection et procede de recuperation assistee de petrole
EP2906596B1 (en) 2012-10-12 2023-12-27 Arizona Board of Regents on behalf of Arizona State University Antibody based reagents that specifically recognize toxic oligomeric forms of tau
WO2017190138A1 (en) * 2016-04-29 2017-11-02 The Regents Of The University Of California Novel methods for quantifying proteins using phage-based sequencing

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2136092T3 (es) * 1991-09-23 1999-11-16 Medical Res Council Procedimientos para la produccion de anticuerpos humanizados.
US6589736B1 (en) * 1994-11-22 2003-07-08 The Trustees Of Boston University Photocleavable agents and conjugates for the detection and isolation of biomolecules
US6699658B1 (en) * 1996-05-31 2004-03-02 Board Of Trustees Of The University Of Illinois Yeast cell surface display of proteins and uses thereof
US6255455B1 (en) * 1996-10-11 2001-07-03 The Trustees Of The University Of Pennsylvania Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
US5985543A (en) * 1996-10-11 1999-11-16 The Trustees Of The University Of Pennsylvania Compositions and methods for detection of antibody binding to cells
GB9722131D0 (en) * 1997-10-20 1997-12-17 Medical Res Council Method
US20040170955A1 (en) * 2000-09-08 2004-09-02 Wadih Arap Human and mouse targeting peptides identified by phage display
US7420030B2 (en) * 2000-09-08 2008-09-02 The Board Of Regents Of The University Of Texas System Aminopeptidase A (APA) targeting peptides for the treatment of cancer
US20040175756A1 (en) * 2001-04-26 2004-09-09 Avidia Research Institute Methods for using combinatorial libraries of monomer domains
US20040048243A1 (en) * 2001-09-07 2004-03-11 Wadih Arap Methods and compositions for in vitro targeting
US7244592B2 (en) * 2002-03-07 2007-07-17 Dyax Corp. Ligand screening and discovery
AU2002368488A1 (en) * 2002-12-23 2004-07-14 Affitech As Process for producing an in vitro peptide expression library
ATE447611T1 (de) * 2003-08-18 2009-11-15 Univ California Polypeptid-display-bibliotheken und verfahren zur herstellung und verwendung davon

Also Published As

Publication number Publication date
EP1802980A1 (en) 2007-07-04
IL181928A0 (en) 2007-07-04
US20080300140A1 (en) 2008-12-04
IL181928A (en) 2011-11-30
CA2579937C (en) 2013-07-02
AU2005291011A1 (en) 2006-04-13
CA2579937A1 (en) 2006-04-13
JP2008515419A (ja) 2008-05-15
WO2006038021A1 (en) 2006-04-13
AU2005291011B2 (en) 2011-10-13
JP4729043B2 (ja) 2011-07-20
DK1802980T3 (da) 2013-03-04
EP1802980B1 (en) 2012-12-05

Similar Documents

Publication Publication Date Title
EP1848672A4 (en) BANKS AND METHODS FOR ISOLATING ANTIBODIES
ZA200608130B (en) Humanized anti-TGF-beta antibodies
SG10201404801YA (en) Monoclonal antibody
IL181575A0 (en) Anti-ox40l antibodies
IL228032A0 (en) Antibodies
IL180852A0 (en) Anti-cd154 antibodies
EP1761566A4 (en) HUMANIZED MONOCLONAL ANTIBODIES ANTI-TAG-72
EP1860120A4 (en) PROCESS FOR AN IMPROVED ANTIBODY
EP1743945A4 (en) SCREENING METHOD
GB0420466D0 (en) Anti-glucan antibodies
IL206072A0 (en) Novel method for generating and screening an antibody library
EP1718749A4 (en) ANTI-AF-20 HUMANIZED MONOCLONAL ANTIBODY
GB0514678D0 (en) Method for high-throughput screening
EP1860185A4 (en) SCREENING METHOD
EP1721971A4 (en) SCREENING PROCESS
ZA200701952B (en) Anti-OX40L antibodies
EP1857817A4 (en) SCREENING PROCESS
HK1105451A1 (en) Methods for antibody library screening
IL215528A (en) Methods will notice training
EP1712564A4 (en) MONOCLONAL ANTIBODY ANTI-NC1
GB0415644D0 (en) Monoclonal antibody
GB0418415D0 (en) Antibody
GB0414810D0 (en) Methods for identifying antibodies
GB0420771D0 (en) Antibody
GB0418428D0 (en) Method for screening

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20161007